| Identification |
| Name: | Benzoic acid,2-hydroxy-, 2-[4-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]-2-oxoethylester, (2S-cis)- (9CI) |
| Synonyms: | 14-salicyloyldaunorubicin |
| CAS: | 116782-68-4 |
| Molecular Formula: | C34H33 N O13 |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C34H33NO13/c1-14-28(38)18(35)10-23(47-14)48-21-12-34(44,22(37)13-46-33(43)15-6-3-4-8-19(15)36)11-17-25(21)32(42)27-26(30(17)40)29(39)16-7-5-9-20(45-2)24(16)31(27)41/h3-9,14,18,21,23,28,36,38,40,42,44H,10-13,35H2,1-2H3 |
| Molecular Structure: |
 |
| Properties |
| Flash Point: | 494.9°C |
| Boiling Point: | 894.7°Cat760mmHg |
| Density: | 1.6g/cm3 |
| Refractive index: | 1.717 |
| Flash Point: | 494.9°C |
| Safety Data |
| |
 |
